AXIM Plans Trials for Flagship Candidate after Receiving GMP License

AXIM Biotechnologies says it plans to proceed with clinical trials for its flagship drug candidate, the cannabinoid-containing chewing gum MedChew Rx ® , after receiving a GMP manufacturing license from the Netherlands’ Ministry of Health, Welfare and Sport.The license, which took effect October 1, will enable AXIM to produce its cannabinoid-based pharmaceutical drug candidates for human clinical trials for multiple indications.“It’s a major milestone for the developme